<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02433041</url>
  </required_header>
  <id_info>
    <org_study_id>2013DR4089</org_study_id>
    <nct_id>NCT02433041</nct_id>
  </id_info>
  <brief_title>Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial</brief_title>
  <acronym>PRIDe</acronym>
  <official_title>Baden PRIDe Trial - Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kantonsspital Baden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out whether postoperative delirium can be more properly
      prevented by the combination of determined preventive agents in past studies. Further on the
      investigators measure pre- and postoperative cortisol, neuron specific enolase (NSE) and
      S-100beta levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The postoperative delirium remains a challenge for medical stuff concerning detection,
      therapy and avoidance of consequences. Over the years numerous risk factors were detected
      which emphasizes the importance of its prevention. Within these studies some possibilities,
      but no strictly defined rules of action for pharmacological or neuropsychological prevention
      are described. This is why in this randomized, double-blinded, placebo-controlled study, the
      investigators want to compare two agents that were found to prevent postoperative delirium to
      a certain level, even in combination: the investigators arrange the patients within four
      study groups, one receiving Haloperidol, one Ketamine, one both and one placebo. The patients
      receive the study drug only once right before induction of anesthesia. After the day of
      recruitment there is the day of operation and a follow-up of three days (5 days of
      observation in total, where the investigators will test cognitive function with Mini Mental
      Status Examination (MMSE), Delirium Observation Scale (DOS), Nursing Delirium Screening Scale
      (Nu-DESC) or Intensive Care Delirium Screening Checklist (ICDSC). Additionally the
      investigators will measure and compare pre- and postoperative Cortisol, NSE and S-100beta
      levels.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Differences among study groups - Significant drop in MMSE of two points in one of the three postoperative follow-up days</measure>
    <time_frame>5 day follow-up (preoperative, day of surgery, postoperative days 1-3)</time_frame>
    <description>Significant drop in MMSE of two points in one of the three postoperative follow-up days (ICU patients excluded)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantification of incidence of postoperative delirium based on cognitive testing and lab parameters</measure>
    <time_frame>5 day follow-up (preoperative, day of surgery, postoperative days 1-3)</time_frame>
    <description>Drop of one point in Nursing Delirium Screening Scale (Nu-DESC) compared pre- and postoperatively, comparison of levels of NSE, S-100beta and Cortisol (significantly elevated postoperatively?)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Postoperative Delirium</condition>
  <arm_group>
    <arm_group_label>Haloperidol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Haloperidol 0.005mg/kg at induction of anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ketamine 1mg/kg at induction of anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Haloperidol + Ketamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Combination of Haloperidol + Ketamine in same dosage at induction of anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline solution (NaCl 0.9%)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Haloperidol</intervention_name>
    <description>Haloperidol 0.005mg/kg at induction of anesthesia</description>
    <arm_group_label>Haloperidol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Ketamine 1mg/kg at induction of anesthesia to test its power to prevent postoperative delirium</description>
    <arm_group_label>Ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Haloperidol + Ketamine</intervention_name>
    <description>Haloperidol 0.005mg/kg + Ketamine 1mg/kg at induction of anesthesia to test their power to prevent postoperative delirium if given together</description>
    <arm_group_label>Haloperidol + Ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline solution (NaCl 0.9%)</intervention_name>
    <description>Placebo being used in one of the four groups</description>
    <arm_group_label>Saline solution (NaCl 0.9%)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 65 years and older

          -  Signed agreement

        Exclusion Criteria:

          -  Delirium at admittance or MMSE score &lt;24 points

          -  High risk for postoperative ICU treatment

          -  Haloperidol or Ketamine intolerance

          -  Risk of lack of cooperation

          -  Drug an alcohol abuse

          -  Dementia

          -  QT interval (QTc) prolongation (at least 460ms in men, at least 470ms women) or drugs
             influencing QT interval, such as class Ia and III antiarrhythmics, Gatifloxacin,
             Moxifloxacin, Pentamidin, Cotrimoxazol, Tacrolimus, Dolasetron

          -  Parkinson's disease

          -  Intake of dopaminergic drugs (Levodopa, dopamine agonists)

          -  Parkinsonism

          -  Epilepsy

          -  Unable to be interviewed (severe Dementia, speaking disorders, intubation, respiratory
             isolation, aphasia, coma, terminal illness)

          -  Delay of operation of more than 72 hours past hospital admittance

          -  Body weight &gt;100kg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexa Hollinger, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Siegemund, MD</last_name>
    <phone>+41613286414</phone>
    <email>martin.siegemund@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexa Hollinger, MD</last_name>
    <phone>+41613286508</phone>
    <email>alexa.hollinger@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Siegemund, MD</last_name>
      <phone>+41613286414</phone>
      <email>martin.siegemund@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Alexa Hollinger, MD</last_name>
      <phone>+41613286508</phone>
      <email>alexa.hollinger@usb.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Harriet Riegger</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katharina Toft</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leonie Faller</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philipp Ruland, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2015</study_first_submitted>
  <study_first_submitted_qc>April 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2015</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postoperative delirium</keyword>
  <keyword>Cortisol</keyword>
  <keyword>NSE</keyword>
  <keyword>S-100beta</keyword>
  <keyword>MMSE</keyword>
  <keyword>Nu-DESC</keyword>
  <keyword>ICDSC</keyword>
  <keyword>DOS</keyword>
  <keyword>Haloperidol</keyword>
  <keyword>Ketamine</keyword>
  <keyword>Combination of Haloperidol and Ketamine</keyword>
  <keyword>Placebo</keyword>
  <keyword>Prevention of</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Haloperidol</mesh_term>
    <mesh_term>Haloperidol decanoate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

